Search for: "PAR PHARMACEUTICALS COMPANIES, INC"
Results 61 - 80
of 90
Sorted by Relevance
|
Sort by Date
29 Jul 2013, 4:00 am
Le Blogue du CRLUne substitution de sûreté peut être obtenue par ordonnance de sauvegardeDans Sarailis c. [read post]
2 Nov 2007, 11:00 pm
: (PLI), (PatentDocs), (Patent Baristas), (Patently'O), Vonage settles patent dispure with Verizon: (IP Law360), Celgene and Novartis file extended release Ritalin suit: (IP Law360), T-Mobile USA is the latest to settle charges that it infringed technology for computerized sales methods held by patent-holding company Orion IP LLC: (IP Law360),Bayer beats Dr Reddy's on Avelox (moxifloxacin): (OrangeBookBlog), (Generic Pharmaceuticals), Martek obtains permanent injunction… [read post]
11 Jun 2014, 6:30 am
©2014 Amaxx Risk Solutions, Inc. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
11 Feb 2013, 6:00 am
Stack, CPA, Director of Operations, Amaxx Risk Solutions, Inc. is an expert in employer communication systems and part of the Amaxx team helping companies reduce their workers compensation costs by 20% to 50%. [read post]
1 Nov 2017, 4:00 am
TD Canada Trust, 2017 SCC 51 [1] A pharmaceutical company was the victim of a fraudulent cheque scheme implemented by one of its employees. [read post]
8 May 2009, 8:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Mircera (Methoxy polyethylene glycol-epoetin beta) – US: Federal Circuit revises Amgen v ITC (Patently-O) (Patent Baristas) (ITC 337 Law Blog) (Hal Wegner) (Patent Docs) General Alicia Greenidge to step down as Director of IFPMA (Intellectual Property Watch) Flu crisis could lead to compulsory licences (Managing… [read post]
20 Mar 2009, 2:05 am
Sterling Drug, Inc., 416 F.2d 417, 426 (2d Cir. 1969).District of Columbia: McNeil Pharmaceutical v. [read post]
18 Feb 2020, 4:00 am
Pfizer Canada ULC, 2020 FC 1, at para. 42. [3] See Sections 27(3)(b) and 28.3 of the Patent Act, RSC 1985, c P-4 [4] Burton Parsons Chemicals, Inc v Hewlett-Packard (Canada) Ltd, [1976] 1 SCR 555 at 563 [5] Apotex Inc v Sanofi-Synthelabo Canada Inc, 2008 SCC 61 at paragraph 37, [2008] 3 SCR 265; see also Bell Helicopter Textron Canada Limitée v Eurocopter, société par actions simplifiée, 2013 FCA 219 at paragraph 65; Mylan… [read post]
7 Sep 2011, 4:22 am
Apotex (Patently-O) Glivec (Imatinib mesylate) – India: The Glivec patent saga – its raining recusals (Spicy IP) Glivec (Imatinib mesylate) – India: Supreme Court to hear Novartis challenge to India’s patent law (IP Watch) Lo Loestrin Fe (Norethindrone acetate / Ethinyl estradiol / Ferrous fumarate) – US: Warner Chilcott files patent infringement complaint against Lupin in response to Para IV certification (Patent Docs) Lumigan (Bimatoprost) – US: Allergan files… [read post]
24 Jun 2013, 10:08 am
Watson Pharmaceuticals, Inc. [5] Citing FTC v. [read post]
24 Jun 2013, 6:08 am
Watson Pharmaceuticals, Inc. [5] Citing FTC v. [read post]
9 Apr 2007, 7:30 am
From the FDA News item entitled "FDA Announces Voluntary Withdrawal of Pergolide Products":The products being withdrawn are Permax, the trade name for pergolide marketed by Valeant Pharmaceuticals, and two generic versions of pergolide manufactured by Par and Teva. [read post]
27 Mar 2009, 8:00 am
(Intellectual Property Watch) Two final thoughts on big pharma acquisitions (IP finance) Brazil: Patent term cutbacks in Brazil and pharmaceutical pipelines – IP Think Tank podcast 23 March 2009 (IP Think Tank) Brazil: Patent term cutbacks - Lobbying, intellectual property and superior courts (IP Think Tank) Brazil: Patent term extension (PTE) under TRIPs revisited and reviewed by Superior Court of Justice (IP tango) Denmark: Harmonisation in Denmark: Patents covering… [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
25 Jul 2017, 8:28 am
Supreme Court in its upcoming term, in the Cyan, Inc. v. [read post]
8 Jul 2009, 7:04 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual Property Watch) Humira (Adalimumab) – US: Largest patent verdict in history – Abbott to pay $1.67 billion to Centocor because Humira found to… [read post]
3 Aug 2023, 3:03 am
In the case at issue, the appellant, Shopify Inc., appealed the decision of the GC T‑222/21, SHOPPI (already commented here), alleging infringement of Article 53(1) of EUTM Regulation no. 207/2009, in conjunction with Article 8(1)(b). [read post]
3 Jan 2011, 9:45 pm
Nursing Homes: PATIENTS SUFFER SUB-PAR CARE AT CALIFORNIA FACILITIES, CLASS ACTION SAYS, Valentine v. [read post]
9 Jan 2023, 9:01 pm
Walgreens After more than seven years of litigation, Walgreens, Inc. [read post]
